BACKGROUND: Percutaneous interventions for renal arterial disease can be used to treat a variety of conditions including both atherosclerotic and non-atherosclerotic renal artery stenosis (RAS) as well as endovascular management of renal artery aneurysms (RAA). AIM: We sought to examine the indications, techniques and results of percutaneous renal angioplasty and stenting in our institution over a 6-year period and review the current evidence for practice. METHODS: Patient demographics, procedure indications, technical procedural details, complications, baseline and follow-up renal profile indices were analysed. RESULTS: The most common indication for intervention was atherosclerotic RAS (69.2%) followed by RAS secondary to fibromuscular dysplasia (15.3%) and RAA (15.3%). There was a 100% technical success in our cohort of patients. The majority of patients (84.6%) had cross-sectional imaging in the form of computed tomography or magnetic resonance angiography prior to intervention. CONCLUSION: When performed in appropriate settings following close liaison with referring physicians, percutaneous renal angioplasty and stenting remains an important treatment modality for renovascular disease.
BACKGROUND: Percutaneous interventions for renal arterial disease can be used to treat a variety of conditions including both atherosclerotic and non-atherosclerotic renal artery stenosis (RAS) as well as endovascular management of renal artery aneurysms (RAA). AIM: We sought to examine the indications, techniques and results of percutaneous renal angioplasty and stenting in our institution over a 6-year period and review the current evidence for practice. METHODS:Patient demographics, procedure indications, technical procedural details, complications, baseline and follow-up renal profile indices were analysed. RESULTS: The most common indication for intervention was atherosclerotic RAS (69.2%) followed by RAS secondary to fibromuscular dysplasia (15.3%) and RAA (15.3%). There was a 100% technical success in our cohort of patients. The majority of patients (84.6%) had cross-sectional imaging in the form of computed tomography or magnetic resonance angiography prior to intervention. CONCLUSION: When performed in appropriate settings following close liaison with referring physicians, percutaneous renal angioplasty and stenting remains an important treatment modality for renovascular disease.
Authors: Timothy P Murphy; Christopher J Cooper; Lance D Dworkin; William L Henrich; John H Rundback; Alan H Matsumoto; Kenneth A Jamerson; Ralph B D'Agostino Journal: J Vasc Interv Radiol Date: 2005-10 Impact factor: 3.464
Authors: B C van Jaarsveld; P Krijnen; H Pieterman; F H Derkx; J Deinum; C T Postma; A Dees; A J Woittiez; A K Bartelink; A J Man in 't Veld; M A Schalekamp Journal: N Engl J Med Date: 2000-04-06 Impact factor: 91.245
Authors: Christopher J Cooper; Timothy P Murphy; Alan Matsumoto; Michael Steffes; David J Cohen; Michael Jaff; Richard Kuntz; Kenneth Jamerson; Diane Reid; Kenneth Rosenfield; John Rundback; Ralph D'Agostino; William Henrich; Lance Dworkin Journal: Am Heart J Date: 2006-07 Impact factor: 4.749
Authors: C S Desai; R Maybury; L S Cummings; L B Johnson; T M Fishbein; R Neville; J K Melancon Journal: Transplant Proc Date: 2011-09 Impact factor: 1.066
Authors: Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler Journal: Ann Intern Med Date: 2009-05-04 Impact factor: 25.391